--- imach/tests/testV1V2.imach	2015/09/16 08:50:20	1.1
+++ imach/tests/testV1V2.imach	2019/05/22 18:56:06	1.2
@@ -1,9 +1,8 @@
-#Imach version 0.98q4, July 2015,INED-EUROREVES-Institut de longevite-Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research 25293121), Intel Software 2015
-#$Revision: 1.1 $ $Date: 2015/09/16 08:50:20 $
+#$Revision: 1.2 $ $Date: 2019/05/22 18:56:06 $
 # ADL ANALYSIS USING SABE 2000 2006 AND 2010 by sex basic model with weights
 #
-title=testV1V2 datafile=data2.txt lastobs=2500 firstpass=1 lastpass=3
-ftol=1.e-08 stepm=24 ncovcol=2 nlstate=2 ndeath=1 maxwav=3 mle=1 weight=1
+title=testV1V2 datafile=data/data2.txt lastobs=2500 firstpass=1 lastpass=3
+ftol=1.e-08 stepm=24 ncovcol=2 nqv=0 ntv=0 nqtv=0 nlstate=2 ndeath=1 maxwav=3 mle=1 weight=1
 model=1+age+V1+V2.
 # Parameters nlstate*nlstate*ncov a12*1 + b12 * age + ...
 12   -8.1682774    0.0847996  0.0  0.2682606 
@@ -49,10 +48,16 @@ model=1+age+V1+V2.
 233 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.
 234 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0. 0.
 # agemin agemax for life expectancy, bage fage (if mle==0 ie no data nor Max likelihood).
-agemin=60 agemax=95 bage=55 fage=95
+agemin=60 agemax=95 bage=60 fage=95 estepm=24 ftolpl=6e-5
 # Observed prevalence period
-begin-prev-date=1/1/2000 end-prev-date=12/12/2006 estepm=1
+begin-prev-date=1/1/2000 end-prev-date=12/12/2006 mov_average=0
 # Health expectancies computed from stable (period) prevalence (pop_based=0) or population based (1)
 pop_based=1
 # Prevalence forecasting
-starting-proj-date=1/1/2007 final-proj-date=12/12/2011 mov_average=0
+#prevforecast=0 starting-proj-date=1/1/1998 final-proj-date=1/1/2002 mobil_average=1
+prevforecast=1 yearsfproj=10 mobil_average=0
+prevbackcast=1 yearsbproj=10 mobil_average=1
+result:V1=0 V2=0
+result:V1=1 V2=0
+result:V1=1 V2=1
+result:V1=0 V2=0